INS and metabolic dysfunction-associated steatohepatitis: When we induced a type-1 diabetic animal model by treating newborn mice with streptozotocin to damage insulin-secreting beta cells in the pancreas50 followed by a HFD, adult mice robustly developed NASH that was significantly accelerated in the presence of TCS23.